Outer membrane vesicles and soluble factors released by probiotic escherichia coli nissle 1917 and commensal ECOR63 enhance barrier function by regulating expression of tight junction proteins in intestinal epithelial cells

Frontiers in Microbiology

Volumn 7, Issue DEC, 2016, Pages

  Alvarez, Carina Shianya ^a   Badia, Josefa ^a   Bosch, Manel ^a   Giménez, Rosa ^a   Baldomà, Laura ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Escherichia coli; Gut microbes; Intestinal barrier; Membrane vesicles; Phylogenetic group B2; Probiotics; TcpC; Tight junctions

Indexed keywords

CLAUDIN; CLAUDIN 14; INTERLEUKIN 22; MESSENGER RNA; PROBIOTIC AGENT; PROTEIN ZO1; PROTEIN ZO2; TIGHT JUNCTION PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; CELL GROWTH; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOFLUORESCENCE TEST; INTESTINE EPITHELIUM CELL; MEMBRANE VESICLE; NONHUMAN; OUTER MEMBRANE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; TCPC GENE; TRANSCRIPTION REGULATION; TRANSEPITHELIAL RESISTANCE; ULCERATIVE COLITIS; UPREGULATION; WESTERN BLOTTING;

EID: 85008881120     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.01981     Document Type: Article

References (49)

1. Aguilera, L., Toloza, L., Giménez, R., Odena, A., Oliveira, E., Aguilar, J., et al. (2014). Proteomic analysis of outer membrane vesicles from the probiotic strain Escherichia coli Nissle 1917. Proteomics 14, 222-229. doi: 10.1002/pmic.201300328
2. Arribas, B., Rodríguez-Cabezas, M. E., Camuesco, D., Comalada, M., Bailón, E., Utrilla, P., et al. (2009). A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice. Br. J. Pharmacol. 157, 1024-1033. doi: 10.1111/j.1476-5381.2009.00270.x
3. Cañas, M. A., Giménez, R., Fábrega, M. J., Toloza, L., Baldomà, L., and Badia, J. (2016). Outer membrane vesicles from the probiotic Escherichia coli Nissle 1917 and the commensal ECOR12 enter intestinal epithelial cells via clathrin-dependent endocytosis and elicit differential effects on DNA damage. PLoS ONE 11:e0160374. doi: 10.1371/journal.pone.0160374
4. Chibbar, R., and Dieleman, L. A. (2015). Probiotics in the management of ulcerative colitis. J. Clin. Gastroenterol. 49, S50-S55. doi: 10.1097/MCG.0000000000000368
5. Cirl, C., Wieser, A., Yadav, M., Duerr, S., Schubert, S., Fisher, H., et al. (2008). Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat. Med. 14, 399-406. doi: 10.1038/nm1734
6. Datsenko, K. A., and Wanner, B. L. (2000). One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U.S.A. 97, 6640-6645. doi: 10.1073/pnas.120163297
7. de la Riva, L., Badia, J., Aguilar, J., Bender, A. B., and Baldomà, L. (2008). The hpx genetic system for hypoxanthine assimilation as a nitrogen source in Klebsiella pneumoniae: gene organization and transcriptional regulation. J. Bacteriol. 190, 7892-7903. doi: 10.1128/JB.01022-08
8. Ewaschuk, J. B., Diaz, H., Meddings, L., Diederichs, B., Dmytrash, A., and Backer, J. (2008). Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G1025-G1034. doi: 10.1152/ajpgi.90227.2008
9. Fábrega, M. J., Aguilera, L., Giménez, R., Varela, E., Cañas, M. A., Antolín, M., et al. (2016). Activation of immune and defense responses in the intestinal mucosa by outer membrane vesicles of commensal and probiotic Escherichia coli strains. Front. Microbiol. 7:705. doi: 10.3389/fmicb.2016.00705
10. Fisher, A., Gluth, M., Weege, F., Ulrich-Frank, P., Wieddenmann, B., Baumgart, C. D., et al. (2014). Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1. Am. J. Physiol. Gastrointest. Liver Phisiol. 306, G218-G228. doi: 10.1152/ajpgi.00095.2013
11. Garrido-Mesa, N., Utrilla, P., Comalada, M., Zorrilla, P., Garrido-Mesa, J., Zarzuelo, A., et al. (2011). The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice. Biochem. Pharmacol. 82, 1891-1900. doi: 10.1016/j.bcp.2011.09.004
12. Grabig, A., Paclik, D., Guzy, C., Dankof, A., Baumgart, D. C., Erckenbrecht, J., et al. (2006). Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2-and toll-like receptor 4-dependent pathways. Infect. Immun. 74, 4075-4082. doi: 10.1128/IAI.01449-05
13. Hering, N. A., Fromm, M., and Schulzke, J. D. (2012). Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics. J. Physiol. 590, 1035-1044. doi: 10.1113/jphysiol.2011.224568
14. Hering, N. A., Richter, J. F., Fromm, A., Wieser, A., Hartmann, S., Günzel, D., et al. (2014). TcpC protein from E. coli Nissle improves epithelial barrier function involving PKCγ and ERK1/2 signaling in HT-29/B6 cells. Mucosal Immunol. 7, 369-378. doi: 10.1038/mi.2013.55
15. Kang, C. S., Ban, M., Choi, E. J., Moon, H. G., Jeon, J. S., Kim, D. K., et al. (2013). Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS ONE 8:e76520. doi: 10.1371/journal.pone.0076520
16. Kruis, W., Fric, P., Pokrotnieks, J., Lukás, M., Fixa, B., Kascák, M., et al. (2004). Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53, 1617-1623. doi: 10.1136/gut.2003.037747
17. Lai, X. H., Wang, S. Y., and Uhlin, B. E. (1999). Expression of cytotoxicity by potential pathogens in the standard Escherichia coli collection of reference (ECOR) strains. Microbiology 145, 3295-3303. doi: 10.1099/00221287-145-11-3295
18. Landy, J., Ronde, E., English, N., Clark, S. K., Hart, A. L., Knight, S. C., et al. (2016). Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer. World J. Gastroenterol. 22, 3117-3126. doi: 10.3748/wjg.v22.i11.3117
19. Le Gall, T., Clermont, O., Gouriou, S., Picard, B., Nassif, X., Denamur, E., et al. (2007). Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains. Mol. Biol. Evol. 24, 2373-2384. doi: 10.1093/molbev/msm172
20. Li, C. H., and Tam, P. K. S. (1998). An iterative algorithm for minimum cross entropy thresholding. Pattern Recognit. Lett. 19, 771-776. doi: 10.1016/S0167-8655(98)57-59
21. Liu, X., Yang, G., Geng, X. R., Cao, Y., Li, N., Ma, L., et al. (2013). Microbial products induce claudin-2 to compromise gut epithelial barrier function. PLoS ONE 8:e68547. doi: 10.137/journal.pone.0068547
22. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-273.
23. Luetting, J., Rosenthal, R., Barmeyer, C., and Schulzke, J. D. (2015). Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation. Tissue Barriers 3, e977176. doi: 10.4161/21688370.2014.977176
24. Martin, R., Chain, F., Miquel, S., Lu, J., Gratadoux, J. J., Sokol, H., et al. (2014). The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models. Inflamm. Bowel Dis. 20, 417-430. doi: 10.1097/01.MIB.0000440815.76627.64
25. Martín, R., Miquel, S., Chain, F., Natividad, J. M., Jury, J., Lu, J., et al. (2015). Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiol. 15:67. doi: 10.1186/s12866-015-0400-1
26. Ochman, H., and Selander, R. K. (1984). Standard reference strains of Escherichia coli from natural populations. J. Bacteriol. 157, 690-693.
27. Olier, M., Marcq, I., Salvador-Cartier, C., Secher, T., Dobrindt, U., Boury, M., et al. (2012). Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity. Gut Microbes 3, 501-509. doi: 10.4161/gmic.21737
28. Oshima, T., and Miwa, H. (2016). Gastrointestinal mucosal barrier function and diseases. J. Gastroenterol. 51, 768-778. doi: 10.1007/s00535-016-1207-z
29. Peterson, L. W., and Artis, D. (2014). Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 14, 141-153. doi: 10.1038/nri3608
30. Rosenthal, R., Milatz, S., Krug, S. M., Oelrich, B., Schulzke, J.-D., Amasheh, S., et al. (2010). Claudin-2, a component of the tight junction, forms a paracellular water channel. J. Cell Sci. 123, 1913-1921. doi: 10.1242/jcs.060665
31. Satake, S., Semba, S., Matsuda, Y., Usami, Y., Chiba, H., Sawada, N., et al. (2008). Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma. Pathol. Int. 58, 156-163. doi: 10.1111/j.1440-1827.2007.02204.x
32. Scaldaferri, F., Gerardi, V., Mangiola, F., Lopetuso, L. R., Pizzoferrato, M., Petito, V., et al. (2016). Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update. World J. Gastroenterol. 22, 5505-5511. doi: 10.3748/wjg.v22.i24.5505
33. Schindelin, J., Arganda-Carreras, I., Frise, E., Kayning, V., Longair, M., Pietzsch, T., et al. (2012). Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676-682. doi: 10.1038/nmeth.2019
34. Schlee, M., Wehkamp, J., Altenhoefer, A., Oelschlaeger, T. A., Stange, E. F., and Fellermann, K. (2007). Induction of human β-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect. Immun. 75, 2399-2407. doi: 10.1128/IAI.01563-06
35. Schubert, S., Nörenberg, D., Clermont, O., Magistro, G., Wieser, A., Romann, E., et al. (2010). Prevalence and phylogenetic history of the TcpC virulence determinant in Escherichia coli. Int. J. Med. Microbiol. 300, 429-434. doi: 10.1016/j.ijmm.2010.02.006
36. Shen, L., Weber, C. R., Raleigh, D. R., Yu, D., and Turner, J. R. (2011). Tight junction pore and leak pathways: a dynamic duo. Annu. Rev. Physiol. 73, 283-309. doi: 10.1146/annurev-physiol-012110-142150
37. Shen, Y., Giardino Torchia, M. L., Lawson, G. W., Karp, C. L., Ashwell, J. D., and Mazmanian, S. K. (2012). Outer membrane vesicles of a human commensal mediate immune regulation and disease protection. Cell Host Microbe 12, 509-520. doi: 10.1016/j.chom.2012.08.004
38. Snyder, G. A., Cirl, C., Jiang, J., Chen, K., Waldhuber, A., Smith, P., et al. (2013). Molecular mechanisms for the subversion of MyD88 signaling by TcpC from virulent uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U.S.A 110, 6985-6990. doi: 10.1073/pnas.121577011031
39. Souza, éL., Elian, S. D., Paula, L. M., Garcia, C. C., Vieira, A. T., Teixeira, M. M., et al. (2016). Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model. J. Med. Microbiol. 65, 201-210. doi: 10.1099/jmm.0.000222
40. Toloza, L., Giménez, R., Fábrega, M. J., Alvarez, C. S., Aguilera, L., Cañas, M. A., et al. (2015). The secreted autotransporter toxin (Sat) does not act as a virulence factor in the probiotic Escherichia coli strain Nissle 1917. BMC Microbiol. 15:250. doi: 10.1186/s12866-015-0591-5
41. Trebichavsky, I., Splichal, I., Rada, V., and Splichalova, A. (2010). Modulation of natural immunity in the gut by Escherichia coli Nissle 1917. Nutr. Rev. 68, 459-464. doi: 10.1111/j.1753-4887.2010.00305.x
42. Turner, J. R. (2009). Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9, 799-809. doi: 10.1038/nri2653
43. Ukena, S. N., Singh, A., Dringenberg, U., Engelhardt, R., Seidler, U., and Hansen, W. (2007). Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS ONE 2:e1308. doi: 10.1371/journal.pone.0001308
44. Umeda, K., Ikenouchi, J., Katahira-Tayama, S., Furuse, K., Sasaki, H., Nakayama, M., et al. (2006). ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation. Cell 126, 741-754. doi: 10.1016/j.cell.2006.06.043
45. Wasilewski, A., Zielinska, M., Storr, M., and Fichna, J. (2015). Beneficial effects of probiotics, prebiotics, synbiotics and psychobiotics in inflammatory bowel disease. Inflamm. Bowel Dis. 21, 1674-1682. doi: 10.1097/MIB.000000000000364
46. Wells, J. M., Rossi, O., Meijerink, M., and van Baarlen, P. (2011). Epithelial crosstalk at the microbiota-mucosal interface. Proc. Natl. Acad. Sci. U.S.A. 108, 4607-4614. doi: 10.1073/pnas.1000092107
47. Yadav, M., Zhang, J., Fischer, H., Huang, W., Lutay, N., Cirl, C., et al. (2010). Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence. PLoS Pathog. 6:e1001120. doi: 10.1371/journal.ppat.1001120
48. Zhang, Y. G., Wu, S., Xia, Y., and Sun, J. (2013). Salmonella infection upregulates the leaky protein claudin-2 in intestinal epithelial cells. PLoS ONE 8:e58606. doi: 10.1371/journal.pone.0058606
49. Zyrek, A., Cichon, C., Helms, S., Enders, C., Sonnenborn, U., and Schmidt, M. A. (2007). Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol. 9, 804-816. doi: 10.1111/j.1462-5822.2006.00836.x